Get the Stockscreener App
5.37
1.10%
-0.06
After Hours:
5.63
0.26
+4.84%
Maravai Lifesciences Holdings Inc stock is traded at $5.37, with a volume of 2.31M.
It is down -1.10% in the last 24 hours and up +11.41% over the past month.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
See More
Previous Close:
$5.43
Open:
$5.33
24h Volume:
2.31M
Relative Volume:
1.31
Market Cap:
$761.70M
Revenue:
$288.95M
Net Income/Loss:
$-119.03M
P/E Ratio:
9.4293
EPS:
0.5695
Net Cash Flow:
$60.67M
1W Performance:
-5.29%
1M Performance:
+11.41%
6M Performance:
-23.40%
1Y Performance:
-15.70%
1-Day Range:
$5.32
$5.62
1-Week Range:
$5.30
$6.01
52-Week Range:
$4.275
$11.55
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Name
Maravai Lifesciences Holdings Inc
Sector
Industry
Phone
(858) 546-0004
Address
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Compare MRVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
5.37 | 761.70M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-24 | Initiated | Guggenheim | Neutral |
| Dec-05-24 | Downgrade | Goldman | Neutral → Sell |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-13-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-10-24 | Initiated | Craig Hallum | Buy |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-08-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-23-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-09-23 | Downgrade | Goldman | Buy → Neutral |
| Jan-05-23 | Downgrade | UBS | Buy → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Nov-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Dec-16-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-15-20 | Initiated | BofA Securities | Buy |
| Dec-15-20 | Initiated | Credit Suisse | Outperform |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-15-20 | Initiated | Jefferies | Buy |
| Dec-15-20 | Initiated | Robert W. Baird | Outperform |
| Dec-15-20 | Initiated | Stifel | Buy |
| Dec-15-20 | Initiated | William Blair | Outperform |
| Dec-14-20 | Initiated | UBS | Buy |
View All
Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News
Maravai Lifesciences initiated with a Neutral at Guggenheim - Yahoo Finance
MRVI Stock Drops 5% Amidst Biotech Sector Decline - GuruFocus.com
Guggenheim starts Maravai LifeSciences stock with neutral rating - Investing.com
Danaher, Cryoport, Sartorius win Buy at Guggenheim (DHR:NYSE) - Seeking Alpha
Guggenheim starts Maravai LifeSciences stock with neutral rating By Investing.com - Investing.com UK
Guggenheim Initiates Coverage on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat
Exploring December 2024's Undervalued Small Caps With Insider Action In US - Simply Wall St
Maravai LifeSciences reduces debt by $228 million - Investing.com
Maravai LifeSciences (NASDAQ:MRVI) Shares Down 4.8%Time to Sell? - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Up 3.8%Here's What Happened - MarketBeat
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Brokerages - Defense World
Maravai LifeSciences' SWOT analysis: stock outlook amid mRNA manufacturing expansion - Investing.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.71 Million Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Traders Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences' SWOT analysis: stock faces challenges amid growth potential - Investing.com Nigeria
Quantinno Capital Management LP Buys 289,141 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Fmr LLC - MarketBeat
Point72 Asset Management L.P. Sells 2,492,812 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Cut to Sell at The Goldman Sachs Group - Defense World
MRVIMaravai LifeSciences Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Acquired by Systematic Financial Management LP - MarketBeat
Maravai LifeScience shares downgraded on long-term growth concerns in early stage programs - Investing.com Nigeria
138,422 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Bought by Readystate Asset Management LP - MarketBeat
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors - GlobeNewswire
4 Analysts Have This To Say About Maravai LifeSciences - Inkl
Is Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Still Trending? - Stocks Register
Maravai LifeSciences (NASDAQ:MRVI) Shares Down 3.5% – Here’s What Happened - Defense World
Maravai LifeSciences (NASDAQ:MRVI) Trading Down 3.5%What's Next? - MarketBeat
(MRVI) Proactive Strategies - Stock Traders Daily
Braidwell LP Reduces Stock Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences Holdings (STU:MAR) Net Income Includin - GuruFocus.com
Maravai LifeSciences Holdings (STU:MAR) Capex-to-Operating-Income : 0.00 (As of Sep. 2024) - GuruFocus.com
Investors Purchase Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat
Massachusetts Financial Services Co. MA Sells 948,778 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences: Still Struggling To Find Its Footing (NASDAQ:MRVI) - Seeking Alpha
Maravai LifeSciences Holdings (MEX:MRVI) Payments of Debt : MXN-108 Mil (TTM As of Sep. 2024) - GuruFocus.com
Jennison Associates LLC Has $24.77 Million Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Principal Financial Group Inc. - MarketBeat
Brokerages Set Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Target Price at $10.33 - MarketBeat
Wolfe Research Initiates Coverage of Maravai LifeSciences Holdings (MRVI) with Peer Perform Recommendation - MSN
Maravai LifeSciences stock plunges 39% amid lowered revenue forecast - MSN
What Do Analysts Think About Maravai LifeSciences Holdings Inc’s (NASDAQ:MRVI) Future? - Stocks Register
Royce & Associates LP Increases Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Trading Down 7.5%Here's What Happened - MarketBeat
(MRVI) Trading Report - Stock Traders Daily
Maravai Lifesciences stock hits 52-week low at $4.68 - Investing.com
Steven Cohen's Strategic Acquisition in Maravai LifeSciences - GuruFocus.com
Maravai LifeSciences shares initiated with Peerperform on positive aspects - Investing.com India
Maravai lifesci director John DeFord acquires $100,625 in stock - Investing.com
Insider Buying: Director John Deford Acquires Shares of Maravai LifeSciences Holdings Inc (MRVI) - GuruFocus.com
Maravai Lifesciences Holdings Inc Stock (MRVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Maravai Lifesciences Holdings Inc Stock (MRVI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HULL CARL | See Remarks |
Nov 11 '24 |
Buy |
5.64 |
175,000 |
987,000 |
175,000 |
| GTCR INVESTMENT XI LLC | Director |
May 28 '24 |
Sale |
9.81 |
9,940,974 |
97,570,660 |
20,150,005 |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):